The proinflammatory molecules associated with increased sST2 levels, ICAM-1 and IL-6, may also increase the recruitment and activation of inflammatory cells to the damaged vasculature and thus are of special importance in MS. This evidence concerns the gene IL6 and myeloid sarcoma.